ATE138200T1 - Das von mca-28a32 erkannte antigen - Google Patents
Das von mca-28a32 erkannte antigenInfo
- Publication number
- ATE138200T1 ATE138200T1 AT91909273T AT91909273T ATE138200T1 AT E138200 T1 ATE138200 T1 AT E138200T1 AT 91909273 T AT91909273 T AT 91909273T AT 91909273 T AT91909273 T AT 91909273T AT E138200 T1 ATE138200 T1 AT E138200T1
- Authority
- AT
- Austria
- Prior art keywords
- epitope
- mca
- antigen
- human
- antigen recognized
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/30—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
- C07K16/3046—Stomach, Intestines
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/5753—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the stomach or small intestine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Biomedical Technology (AREA)
- Genetics & Genomics (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Animal Behavior & Ethology (AREA)
- Toxicology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Gastroenterology & Hepatology (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Microbiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Lubrication Of Internal Combustion Engines (AREA)
- Investigating Or Analysing Materials By Optical Means (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US50837390A | 1990-04-12 | 1990-04-12 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE138200T1 true ATE138200T1 (de) | 1996-06-15 |
Family
ID=24022500
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT91909273T ATE138200T1 (de) | 1990-04-12 | 1991-04-10 | Das von mca-28a32 erkannte antigen |
Country Status (12)
| Country | Link |
|---|---|
| EP (1) | EP0537168B1 (de) |
| JP (1) | JPH05507470A (de) |
| KR (1) | KR100206061B1 (de) |
| AT (1) | ATE138200T1 (de) |
| AU (1) | AU660927B2 (de) |
| CA (1) | CA2079601A1 (de) |
| DE (1) | DE69119591T2 (de) |
| DK (1) | DK0537168T3 (de) |
| ES (1) | ES2090331T3 (de) |
| FI (1) | FI924576L (de) |
| GR (1) | GR3020387T3 (de) |
| WO (1) | WO1991016629A1 (de) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0613560B2 (de) * | 1991-11-12 | 2006-06-21 | Prana Biotechnology Ltd | Verfahren zur bestimmung und behandlung von alzheimer-krankheit |
| US6969518B2 (en) | 1998-12-28 | 2005-11-29 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of breast cancer |
| US7598226B2 (en) | 1998-12-28 | 2009-10-06 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of breast cancer |
| US6387697B1 (en) | 1998-12-28 | 2002-05-14 | Corixa Corporation | Compositions for treatment and diagnosis of breast cancer and methods for their use |
| AU1807401A (en) | 1999-11-30 | 2001-06-12 | Corixa Corporation | Compositions and methods for therapy and diagnosis of breast cancer |
| WO2001073027A2 (en) * | 2000-03-24 | 2001-10-04 | Corixa Corporation | Compositions and methods for therapy and diagnosis of colon cancer |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ210867A (en) * | 1984-01-31 | 1989-01-06 | Litton Bionetics Inc | Tumour-specific monoclonal antibodies, production thereof and use |
| DK172686A (da) * | 1985-04-22 | 1986-10-23 | Hybritech Inc | Antigen opnaaet ud fra humant vaev, fremgangsmaade til under anvendelse af antigenet at fremstille monoklonale antistoffer til diagnose og behandling af cancer, fremgangsmaade til paavisning af cancer, samt antistoffer mod antigenet |
| EP0328578B1 (de) * | 1987-07-02 | 1996-05-08 | Akzo Nobel N.V. | Von mca 16-88 erkanntes antigen |
-
1991
- 1991-04-10 WO PCT/US1991/002459 patent/WO1991016629A1/en not_active Ceased
- 1991-04-10 AT AT91909273T patent/ATE138200T1/de not_active IP Right Cessation
- 1991-04-10 DK DK91909273.4T patent/DK0537168T3/da active
- 1991-04-10 AU AU77884/91A patent/AU660927B2/en not_active Ceased
- 1991-04-10 CA CA002079601A patent/CA2079601A1/en not_active Abandoned
- 1991-04-10 ES ES91909273T patent/ES2090331T3/es not_active Expired - Lifetime
- 1991-04-10 DE DE69119591T patent/DE69119591T2/de not_active Expired - Fee Related
- 1991-04-10 FI FI924576A patent/FI924576L/fi unknown
- 1991-04-10 KR KR1019920702530A patent/KR100206061B1/ko not_active Expired - Fee Related
- 1991-04-10 JP JP91508604A patent/JPH05507470A/ja active Pending
- 1991-04-10 EP EP91909273A patent/EP0537168B1/de not_active Expired - Lifetime
-
1996
- 1996-06-28 GR GR960401756T patent/GR3020387T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| GR3020387T3 (en) | 1996-09-30 |
| FI924576A0 (fi) | 1992-10-09 |
| EP0537168B1 (de) | 1996-05-15 |
| EP0537168A1 (de) | 1993-04-21 |
| WO1991016629A1 (en) | 1991-10-31 |
| FI924576A7 (fi) | 1992-10-09 |
| DE69119591D1 (de) | 1996-06-20 |
| KR100206061B1 (ko) | 1999-07-01 |
| AU660927B2 (en) | 1995-07-13 |
| ES2090331T3 (es) | 1996-10-16 |
| CA2079601A1 (en) | 1991-10-13 |
| EP0537168A4 (en) | 1993-05-05 |
| DK0537168T3 (da) | 1996-09-02 |
| DE69119591T2 (de) | 1996-09-12 |
| JPH05507470A (ja) | 1993-10-28 |
| AU7788491A (en) | 1991-11-11 |
| FI924576L (fi) | 1992-10-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK0528767T3 (da) | antistofderivater | |
| KR880700061A (ko) | 인체 암종양과 관련된 항원에 대한 단클론성 항체 | |
| ES539987A0 (es) | Un procedimiento para preparar un anticuerpo monoclonal hu- mano | |
| NO941370L (no) | Rekombitope peptider | |
| AU625171B2 (en) | Specific excretion-secretion antigens of toxoplasma gondii, their expression products, processes for obtaining them and their diagnostic and prophylactic uses | |
| DE69119591D1 (de) | Das von mca-28a32 erkannte antigen | |
| ATE137674T1 (de) | Von mca 16-88 erkanntes antigen | |
| EP0420848A4 (en) | Carcinoma-associated antigens, and antibodies which recognize these antigens | |
| NO862097L (no) | Monoklonale antistoffer for humane ikke-smaacelle lungekarsinoma. | |
| KR930700850A (ko) | 엠씨에이 28에이 32(m32)에 의해 인식되는 항원, 씨티에이에이 28에이 32(ct 28a32) | |
| DE3784364D1 (de) | Tumorassoziiertes antigen. | |
| ATE183546T1 (de) | Tumorspezifischer monoklonaler antikörper 81av78 | |
| NO924803L (no) | Tumor-relatert monoklonalt antistoff 88bv59 | |
| Fritz | IMMUNOLOGICAL INVESTIGATIONS WITH MONOCLONAL ANTIBODY SPECIFIC FOR A LEWIS LUNG TUMOR-ASSOCIATED MEMBRANE ANTIGEN. | |
| DK182188A (da) | Humant tumorassocieret antigen | |
| ATE95426T1 (de) | Humanes karcinom-assoziertes antigen und an dieses antigen bindende antikoerper. | |
| FI923418L (fi) | Monoklonaalinen vasta-aine |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| REN | Ceased due to non-payment of the annual fee |